Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases

被引:0
|
作者
Zhenhong Wang
Jian An
Chaohua Wang
机构
[1] Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics,Department of Gynecology
[2] Fujian Medical University,Department of Gynecology, Women and Children’s Hospital, School of Medicine
[3] Xiamen University,Department of Gynecology and Obstetrics
[4] Peking University People’s Hospital,undefined
来源
关键词
Chemotherapy; Premature ovarian failure; Perimenopausal symptoms; Myeloablative regimen; Leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist
    Ozcelik, Bulent
    Turkyilmaz, Cagdas
    Ozgun, Mahmut Tuncay
    Serin, Ibrahim Serdar
    Batukan, Cem
    Ozdamar, Saim
    Ozturk, Ahmet
    FERTILITY AND STERILITY, 2010, 93 (05) : 1609 - 1614
  • [42] Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
    Tsui, Kuan-Hao
    Lee, Wen-Ling
    Seow, Kok-Min
    Yang, Lin-Wei
    Wang, Shih-Yi
    Wang, Peng-Hui
    Chang, Chi-Lun
    Yen, Ming-Shyen
    Cheng, Jiin-Tsuey
    Chen, Chih-Ping
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2014, 53 (01): : 35 - 42
  • [43] UTILIZATION OF GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PRESERVATION OF OVARIAN FUNCTION IN WOMEN WITH BREAST CANCER RECEIVING CHEMOTHERAPY.
    Vitez, Sally F.
    Chen, Ling
    Brady, Paula C.
    Wright, Jason D.
    FERTILITY AND STERILITY, 2019, 112 (03) : E112 - E112
  • [44] PITUITARY AND OVARIAN SUPPRESSION RATE AFTER HIGH DOSAGE OF GONADOTROPIN-RELEASING HORMONE AGONIST
    BIDER, D
    GOLDENBERG, M
    BENRAFAEL, Z
    MASHIACH, S
    SHALEV, J
    BLANKSTEIN, J
    FERTILITY AND STERILITY, 1989, 51 (04) : 578 - 581
  • [45] EFFECT OF AN ANTAGONISTIC ANALOG OF GONADOTROPIN-RELEASING HORMONE UPON OVARIAN GRANULOSA-CELL FUNCTION
    HSUEH, AJW
    LING, NC
    LIFE SCIENCES, 1979, 25 (14) : 1223 - 1230
  • [46] Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer
    Lambertini, Matteo
    Falcone, Tommaso
    Unger, Joseph M.
    Phillips, Kelly-Anne
    Del Mastro, Lucia
    Moore, Halle C. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 804 - 805
  • [47] Efficacy of Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in Women with Systemic Lupus Erythematosus (SLE) Receiving Cyclophosphamide (CYC)
    Chu, Jun
    Abid, Dania
    Manna, Zerai
    Paul, Subrata
    Ochoa, Isabel
    Wu, Yalan
    Goyal, Sonia
    Naqvi, Syed Ali Abbas
    Hooda, Lubna
    Hasni, Sarfaraz
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2979 - 2981
  • [48] Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors
    Blumenfeld, Zeev
    Zur, Hilli
    Dann, Eldad J.
    ONCOLOGIST, 2015, 20 (11): : 1283 - 1289
  • [49] Prediction of ovarian function recovery after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in young breast cancer patients
    Lee, D. Y.
    Mok, C. W.
    Choi, D.
    HUMAN REPRODUCTION, 2017, 32 : 373 - 373
  • [50] Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
    Poggio, Francesca
    Lambertini, Matteo
    Bighin, Claudia
    Conte, Benedetta
    Blondeaux, Eva
    D'Alonzo, Alessia
    Dellepiane, Chiara
    Buzzatti, Giulia
    Molinelli, Chiara
    Boccardo, Francesco
    Del Mastro, Lucia
    CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH, 2019, 13